Yenepoya Foundation invites applications for scholarships

Mangaluru, May 19: Team Be Human, a city based group of philanthropists, has taken commendable initiative to satiate the hunger of the civic workers of Mangaluru City Corporation that are endangering their lives to keep the city clean amidst covid-19 lockdown. 

On Friday, April 18, gorcesary kits were distributed among around 180 civic workers at Eidgah Maidan in Light House Hill in the presence of Corporator Abdul Raoof Bajal, Mansoor Ahmed Azad, Aina group Ashraf, Ceco Asif, Advocate Abdul Shukoor, U B Saleem, Sahil Zaheer, Rash Beary, Munna Kammaradi and Abdul Muttalib.

The Team swung into action on hearing the civic workers' plight due to the delay in payment of their wages by the Antony Waste Management firm. The Team was helped by the alumni of the St Aloysius College, Mangaluru (batch 1989). 

This is not the first time the Team Be Human distributing kits among the needy. Amidst lockdown it has already distributed around 1200 grocery kits among the poor people including the daily wage workers, migrant labourers in Dakshina Kannada district with help of Ahnaf Deals, Altaf, Shameem, Basha, Pradeep, Vincent,  Shiyaz Deals, Nawaz and Haneef. 

In its next step the Team Be Human is planning to distribute the kits among civic workers in Urva and Suratkal region, said Asif Deals, founder president of Team Be Human. He called upon the youth and students to come forward to help the needy and poor people who are deprived of basic facilities.

Bengaluru, May 7: Karnataka has revised its standard operating procedure (SOP) for international passengers. The first group of passengers will arrive in the state on May 8.

The number of categories has been reduced to two from three. Category A includes passengers symptomatic on arrival while Category B passengers are those asymptomatic on arrival. These are passengers who are either healthy or those having co-morbidities.

As per the revised SOP, the passenger will be released on the seventh day, if tested negative, to strict home quarantine for another seven days with stamping.

This norm is in contradiction to the Ministry of Home Affairs’ SOP for international passengers. As per the MHA’s SOP, the passengers (asymptomatic) will be under institutional quarantine for 14 days. Testing negative after 14 days, they will be allowed to go home and will undertake self-monitoring of their health for 14 more days.

On the contradiction, Pandey said, "We don't take chances as we rely on tests instead of just quarantining. Other states may be depending on just 14-day institutional quarantine."

"GOI SOP doesn't talk about Covid tests on international passengers. We have put an additional safety layer of three Covid tests on returnees -- one on arrival, second from 5-7 days and last on 12th day. This will ensure definite identification of positive cases even if they are asymptomatic and their subsequent treatment. We should look at the spirit behind the order," he added.

On the 14-day additional reporting period for category B, he said, "It is implied as category B patients should report to us for 14 days after their first 14-day quarantine period is over."

Medical Education Minister Dr K Sudhakar said that the State would follow the Centre’s norms.

Till Tuesday, Karnataka’s SOP had three categories. Under Category A (symptomatic), 14-day institutional quarantine at COVID-19 Health Care Centre was mandatory followed by 14-day reporting period. Under Category B (asymptomatic above 60 years with co-morbidities), seven-day institutional quarantine at hotel/hostel followed by seven-day home quarantine and 14-day reporting period had been recommended. The 14-day home quarantine and 14-day reporting period was mandatory for Category C (asymptomatic).

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.